Evidence map›Paper›PMID 37261858›Full record

ArticleJournal of the National Cancer Institute2023

Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia.

Puja J Umaretiya, Victoria B Koch, Yael Flamand, Rahela Aziz-Bose, Lenka Ilcisin, Ariana Valenzuela, Peter D Cole, Lisa M Gennarini, Justine M Kahn, Kara M Kelly and 6 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of the National Cancer Institute, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Targeting hardship: poverty as a modifiable risk factor in childhood leukemia and lymphoma treatment.Hematology. American Society of Hematology. Education Program · 2024
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Puja J UmaretiyaDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0002-7587-4875
Victoria B KochDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Yael FlamandDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Rahela Aziz-BoseDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Lenka IlcisinDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ariana ValenzuelaDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Peter D ColeRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Lisa M GennariniMontefiore Medical Center, Bronx, NY, USA.
Justine M KahnDivision of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia, University Medical Center, New York, NY, USA.
Kara M KellyDepartment of Pediatrics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Thai Hoa TranDivision of Pediatric Hematology Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada.
Bruno MichonCentre Hospitalier Universitaire de Quebec, Saint-Foy, QC, Canada.
Jennifer J G WelchDivision of Pediatric Hematology/Oncology, Hasbro Children's Hospital, Brown University, Providence, RI, USA.
Joanne WolfeDivision of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Lewis B SilvermanDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Kira BonaDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-5602-7059
Boston Children's Hospital · USDana-Farber Cancer Institute · USBrigham and Women's Hospital · USBrown University · USCentre hospitalier universitaire de Québec · CACentre Hospitalier Universitaire Sainte-Justine · CAColumbia University Irving Medical Center · USMontefiore Medical Center · USRoswell Park Comprehensive Cancer Center · USRutgers, The State University of New Jersey · US

Funding

Research Training in Pediatric OncologyT32CA136432 · NCI · DANA-FARBER CANCER INST · PI SCOTT A ARMSTRONG · 2009 to 2026
$7.9M
Material Hardship as a Targetable Measure of Poverty in Pediatric CancerK07CA211847 · NCI · DANA-FARBER CANCER INST · PI BONA, KIRA O. · 2016 to 2021
$731k
NCI NIH HHS K07 CA211847NCI NIH HHS T32 CA136432
6 · The paper itself

Abstract

backgroundParent psychological distress during childhood cancer treatment has short- and long-term implications for parent, child, and family well-being. Identifying targetable predictors of parental distress is essential to inform interventions. We investigated the association between household material hardship (HMH), a modifiable poverty-exposure defined as housing, food, or utility insecurity, and severe psychological distress among parents of children aged 1-17 years with acute lymphoblastic leukemia (ALL) enrolled on the multicenter Dana-Farber ALL Consortium Trial 16-001.

methodsThis was a secondary analysis of parent-reported data. Parents completed an HMH survey within 32 days of clinical trial enrollment (T0) and again at 6 months into therapy (T1). The primary exposure was HMH at T0 and primary outcome was severe parental distress at T0 and T1, defined as a score greater than or equal to 13 on the Kessler-6 Psychological Distress Scale. Multivariable models were adjusted for ALL risk group and single parent status.

resultsAmong 375 evaluable parents, one-third (32%; n = 120/375) reported HMH at T0. In multivariable analyses, T0 HMH was associated with over twice the odds of severe psychological distress at T0 and T1 HMH was associated with over 5 times the odds of severe distress at T1.

conclusionsDespite uniform clinical trial treatment of their children at well-resourced pediatric centers, HMH-exposed parents-compared with unexposed parents-experienced statistically significantly increased odds of severe psychological distress at the time of their child's leukemia diagnosis, which worsened 6 months into therapy. These data identify a high-risk parental population who may benefit from early psychosocial and HMH-targeted interventions to mitigate disparities in well-being.

Indexed as

PovertyPrecursor Cell Lymphoblastic Leukemia-LymphomaChildHumansParentsRisk FactorsStress, PsychologicalSurveys and Questionnaires

Identifiers

PMID37261858
PMCPMC10560600
OpenAlexW4378952105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.